Get the Stockscreener App
2.57
8.21%
-0.23
After Hours:
2.67
0.10
+3.89%
Absci Corp stock is traded at $2.57, with a volume of 2.79M.
It is down -8.21% in the last 24 hours and down -16.83% over the past month.
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
See More
Previous Close:
$2.80
Open:
$2.625
24h Volume:
2.79M
Relative Volume:
0.83
Market Cap:
$386.45M
Revenue:
$4.21M
Net Income/Loss:
$-97.67M
P/E Ratio:
-2.7634
EPS:
-0.93
Net Cash Flow:
$-70.76M
1W Performance:
-5.17%
1M Performance:
-16.83%
6M Performance:
+7.98%
1Y Performance:
-24.85%
1-Day Range:
$2.56
$2.73
1-Week Range:
$2.56
$2.86
52-Week Range:
$2.01
$5.228
Absci Corp Stock (ABSI) Company Profile
Name
Absci Corp
Sector
Industry
Phone
(360) 949-1041
Address
18105 SE MILL PLAIN BLVD, VANCOUVER
Compare ABSI vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABSI
Absci Corp
|
2.57 | 421.04M | 4.21M | -97.67M | -70.76M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.27 | 123.47B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
766.66 | 83.60B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
748.72 | 46.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
318.65 | 43.11B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
297.04 | 34.79B | 4.98B | 69.60M | 525.67M | 0.5198 |
Absci Corp Stock (ABSI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-26 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-02-25 | Initiated | JP Morgan | Overweight |
| Jul-03-25 | Resumed | Morgan Stanley | Overweight |
| Jan-22-25 | Initiated | Needham | Buy |
| Oct-02-24 | Initiated | Guggenheim | Buy |
| Jul-03-24 | Initiated | Morgan Stanley | Overweight |
| Mar-14-24 | Initiated | Scotiabank | Sector Outperform |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Overweight |
| May-04-23 | Initiated | H.C. Wainwright | Buy |
| Aug-12-22 | Downgrade | JP Morgan | Overweight → Underweight |
| Jul-18-22 | Initiated | Truist | Buy |
| Mar-02-22 | Resumed | Cowen | Market Perform |
| Feb-01-22 | Initiated | Berenberg | Buy |
| Nov-10-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Aug-16-21 | Initiated | BofA Securities | Neutral |
| Aug-16-21 | Initiated | Cowen | Market Perform |
| Aug-16-21 | Initiated | Credit Suisse | Outperform |
| Aug-16-21 | Initiated | Stifel | Hold |
View All
Absci Corp Stock (ABSI) Latest News
Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer - The Manila Times
Absci names Ransi Somaratne as chief medical officer - Investing.com
Absci brings former Vertex leader to drive AI-designed therapeutics pipeline - Stock Titan
Absci Conference: Agentic AI Push and ABS-201 Hair-Loss Program Take Center Stage - Yahoo Finance
ABSI Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Activity Recap: Is now the right time to enter Absci Corporation - baoquankhu1.vn
Absci (ABSI) CEO McClain exercises options and withholds shares for taxes - Stock Titan
Absci to Report Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results on March 24, 2026 - The Manila Times
AI drug developer Absci to reveal 2025 results in March webcast - Stock Titan
Absci Corporation (NASDAQ:ABSI) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
ABSI stock up on initiating dosing in androgenetic alopecia study - MSN
ABSI Technical Analysis & ETF Price Forecast - Intellectia AI
Absci to Participate in Upcoming Investor Conferences - 富途牛牛
AI-driven drug developer Absci lines up four March investor events - Stock Titan
In the Wake of Absci Corporation's (NASDAQ:ABSI) Latest US$75m Market Cap Drop, Institutional Owners May Be Forced to Take Severe Actions - 富途牛牛
Insiders Who Purchased US$582.6k Of Absci Stock May Not Have Expected 17% Tumble - simplywall.st
Absci (NASDAQ: ABSI) SVP has shares withheld to cover RSU taxes - Stock Titan
OpenAI considers backing AI-led drug discovery firms: report - Seeking Alpha
Absci Corporation: Drawing Potential Insights On ABS-101 And ABS-201 (NASDAQ:ABSI) - Seeking Alpha
What is Absci Corporation’s valuation compared to sectorFed Meeting & Growth Focused Stock Reports - mfd.ru
Absci Corporation (NASDAQ:ABSI) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Absci Corporation's (NASDAQ:ABSI) recent 12% pullback adds to one-year year losses, institutional owners may take drastic measures - Yahoo Finance
Sentiment Review: Is Charter Communications Inc stock a buy or sellBull Run & AI Forecasted Entry/Exit Points - baoquankhu1.vn
EPS Watch: Can Absci Corporation lead its sector in growth2025 Volatility Report & Safe Capital Allocation Plans - baoquankhu1.vn
H.B. Fuller, Caledonia Mining And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
Absci Unveils Origin-1 AI Model, Teases 2025 Hair-Loss Data and Q4 Endometriosis Trial Launch - Yahoo Finance
Absci Corp Presents Business Update at J.P. Morgan Healthcare Conference - TradingView
Analysts Cut Absci (ABSI) Target, Spotlight New Alopecia Therapy in Early Trials - Finviz
10 Best Penny Stocks to Buy for 2026 - Insider Monkey
JonesTrading Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $9 - 富途牛牛
Absci (NASDAQ:ABSI) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
How Absci Corporation stock benefits from global expansionEarnings Trend Report & Real-Time Market Trend Scan - ulpravda.ru
Will Absci Corporation stock benefit from commodity pricesJuly 2025 Weekly Recap & Real-Time Buy Signal Notifications - Улправда
What dividend safety score for Absci Corporation stockMarket Trend Review & Target Return Focused Picks - Улправда
Published on: 2026-01-08 23:53:06 - ulpravda.ru
Absci (NASDAQ:ABSI) Shares Down 9.1%Here's What Happened - MarketBeat
Morgan Stanley downgrades Absci stock on TL1A setback and higher risk profile - Investing.com Nigeria
Morgan Stanley Downgrades Absci Corp(ABSI.US) to Hold Rating, Cuts Target Price to $4.32 - 富途牛牛
How resilient is Absci Corporation stock in market downturnsEarnings Miss & AI Optimized Trade Strategies - moha.gov.vn
Absci Corporation (ABSI) Reports Q2 Loss, Misses Revenue Estimates - MSN
Absci Corporation (NASDAQ:ABSI) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Absci Corp | 4: Statement of changes in beneficial ownership of securities-Director VAN HOUTEN FRANS - 富途牛牛
Absci Corporation (ABSI) Investor Outlook: Unpacking a 136% Potential Upside in Biotech Innovation - DirectorsTalk Interviews
Absci Unveils Preclinical Data for AI-Designed ABS-201, Targeting a Novel Hormonal Pathway for Hair Loss Treatment - Finviz
Absci Corporation (ABSI) Announces First Participants Dosed In Phase 1/2a HEADLINE Trial - Finviz
Morgan Stanley Assumes Coverage on Absci Corporation (ABSI) with $7 Target - MSN
10 Best Biotech Penny Stocks to Buy According to Analysts - Insider Monkey
Absci Corporation (ABSI) Draws Full Buy Consensus With 150% Upside Potential - Finviz
Absci Corp Stock (ABSI) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.71%
0.02%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):